Interventional, open-label study investigating the absorption, metabolism and excretion (AME) of the research medication following a single oral dose of the 14C-labeled research medication to healthy men

Interventional, open-label study investigating the absorption, metabolism and excretion (AME) of the research medication following a single oral dose of the 14C-labeled research medication to healthy men - 15867A (CS0209)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON40688

Enrollment

Registered

2014-03-04

Start date

2014-03-27

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mental disorder

Interventions

The study will start with a screening. At the screening a physical examination will take place and a few other standard medical assessments will be performed (ECG, vital signs). Furthermore a blood

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy male

Exclusion criteria

Exclusion criteria: Clinical significant abnormalities at medical research

Design outcomes

Primary

Measure	Time frame
AME endpoints	—

Secondary

Measure	Time frame
Safety	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)